Risperidon (risperdal) therapy in schizophrenia: metabolic effects

2009-10-01
Yanık, Tülin
Sutcigil, Levent
Ozgen, Fuat

Suggestions

QSAR analysis of a set of benzimidazole derivatives based on their tuberculostatic activities
Geban, Ömer; Ozden, S (1996-01-01)
A set of benzimidazole derivatives previously tested for their tuberculostatic activities was analyzed using the quantitative structure activity relationship (QSAR) method. The activity contributions for structural and substituent effects were determined from the correlation equations which were derived using stepwise regression technique. The resulting QSAR showed that the activity contributions of benzimidazoles depend on the size of the substituents at R(2), the field effect of the substituents at R(1) a...
THE ROLE OF SULT1A1 AND EPHX1 POLYMORPHISMS AS RISK MODIFIERS IN CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA IN TURKISH POPULATION: A CASE-CONTROL STUDY
Tumer, Tugba Boyunegmez; Ulusoy, Gulen; Adalı, Orhan; Sahin, Gurses; Arinc, Emel (2008-01-01)
Comparison of the in vitro DNA-damaging potential of the two anticancer drugs idarubicin and mitomycin C in the presence of NADPH-cytochrome P450 reductase
Celik, Haydar; Arinc, Emel (2006-01-01)
SIGNIFICANCE OF CYP2E1 AND NQO1 POLYMORPHISMS IN THE RISK OF DEVELOPMENT OF CHILDHOOD ACUTE LYMPHOBLASTIC LEUKEMIA
Ulusoy, Gulen; Tumer, Tugba Boyunegmez; Adalı, Orhan; Sahin, Gurses; Arinc, Emel (2008-01-01)
Aldose reductase natural inhibitors from ethyl acetate extracts from southern Turkey
Onay, Melih; Çoruh, Nursen; Isgor, Belgin (2010-08-01)
Citation Formats
T. Yanık, L. Sutcigil, and F. Ozgen, “Risperidon (risperdal) therapy in schizophrenia: metabolic effects,” 2009, vol. 41, Accessed: 00, 2020. [Online]. Available: https://hdl.handle.net/11511/54666.